There is emerging interest in adaptive platform trials for inflammatory bowel disease. In this Comment, we present the results of a workshop that was convened to consider the opportunities and ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Companies have been battling with a lack of private investment in recent years but could now face a lack of government funds.

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

A new search tool unveiled Friday increases public access to information about the connections between advisors to the ...

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

"Many people feel big Pharma actually feared me more than they feared Bobby because of my credibility and my knowledge of ...